Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells

Steroids

Volumn 74, Issue 7, 2009, Pages 586-594

  Santen, Richard J ^a   Fan, Ping ^a   Zhang, Zhenguo ^a   Bao, Yongde ^a   Song, Robert X D ^a   Yue, Wei ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

c Src; EGF receptor; Estrogen receptor alpha; IGF I receptor; MCF 7; MMP2 9

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; STEROID RECEPTOR; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL PROTECTION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST NEOPLASMS; CELL NUCLEUS; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 63649117164     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.11.020     Document Type: Article

References (26)

1. Ali S., and Coombes R.C. Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 5 (2000) 271-281
2. Yee D., and Lee A.V. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 5 (2000) 107-115
3. Cheskis B.J. Regulation of cell signalling cascades by steroid hormones. J Cell Biochem 93 (2004) 20-27
4. Alexaki V.I., Charalampopoulos I., Kampa M., Vassalou H., Theodoropoulos P., Stathopoulos E.N., et al. Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J 18 (2004) 1594-1596
5. Nicholson S., Wright C., Sainsbury J.R., Halcrow P., Kelly P., Angus B., et al. Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J Steroid Biochem Mol Biol 37 (1990) 811-814
6. Baserga R., Peruzzi F., and Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer 107 (2003) 873-877
7. Santen R.J., Song R.X., Zhang Z., Yue W., and Kumar R. Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer. Clin Cancer Res 10 (2004) 337S-345S
8. Song R.X., Barnes C.J., Zhang Z., Bao Y., Kumar R., and Santen R.J. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci U S A 101 (2004) 2076-2081
9. Knowlden J.M., Hutcheson I.R., Barrow D., Gee J.M., and Nicholson R.I. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor. Endocrinology 146 (2005) 4609-4618
10. Hart S., Fischer O.M., Prenzel N., Zwick-Wallasch E., Schneider M., Hennighausen L., et al. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways. Biol Chem 386 (2005) 845-855
11. Adams T.E., McKern N.M., and Ward C.W. Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor. Growth Factors 22 (2004) 89-95
12. Ravichandran K.S. Signaling via Shc family adapter proteins. Oncogene 20 (2001) 6322-6330
13. Hackel P.O., Zwick E., Prenzel N., and Ullrich A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11 (1999) 184-189
14. Luttrell L.M., Daaka Y., and Lefkowitz R.J. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11 (1999) 177-183
15. Zwick E., Hackel P.O., Prenzel N., and Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 20 (1999) 408-412
16. Hallak H., Seiler A.E., Green J.S., Ross B.N., and Rubin R. Association of heterotrimeric G(i) with the insulin-like growth factor-I receptor. Release of G(betagamma) subunits upon receptor activation. J Biol Chem 275 (2000) 2255-2258
17. El Shewy H.M., Kelly F.L., Barki-Harrington L., and Luttrell L.M. Ectodomain shedding-dependent transactivation of epidermal growth factor receptors in response to insulin-like growth factor type I. Mol Endocrinol 18 (2004) 2727-2739
18. Roudabush F.L., Pierce K.L., Maudsley S., Khan K.D., and Luttrell L.M. Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 275 (2000) 22583-22589
19. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., and Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275 (2000) 18447-18453
20. Pietras R.J. Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature. Breast J 9 (2003) 361-373
21. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., et al. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol Endocrinol 16 (2002) 116-127
22. Song R.X., Mor G., Naftolin F., McPherson R.A., Song J., Zhang Z., et al. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17{beta}-estradiol. J Natl Cancer Inst 93 (2001) 1714-1723
23. Song R.X., Zhang Z., Chen Y., Bao Y., and Santen R.J. Estrogen signaling via a linear pathway involvoing insulin like growth factor I receptor, matrix metaloproteinases, and epidermal growth factor receptor to activate mitogen activated protein kinase in MCF-7 breast cancer cells. Endocrinology 148 (2007) 4091-4101
24. Fan P., Wang J.P., Santen R.J., and Yue W. Long term treatment with tamoxifen facilitates translocation of estrogen receptor α out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Cancer Res 67 (2007) 1352-1360
25. Hutcheson I.R., Knowlden J.M., Madden T.A., Barrow D., Gee J.M., Wakeling A.E., et al. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells. Breast Cancer Res Treat 81 (2003) 81-93
26. Richards R.G., DiAugustine R.P., Petrusz P., Clark G.C., and Sebastian J. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc Natl Acad Sci U S A 93 (1996) 12002-12007